Literature DB >> 21705979

GH deficiency in adult B-thalassemia major patients and its relationship with IGF-1 production.

Angela Ida Pincelli1, Nicoletta Masera, Luisa Tavecchia, Mario Perotti, Silvia Perra, Raffaela Mariani, Alberto Piperno, Giuseppe Mancia, Guido Grassi, Giuseppe Masera.   

Abstract

Endocrine complications in Β-thalassemia represent a prominent cause of morbidity. Above all, dysfunction of GH-IGF-1 axis is of a major concern because of its pathogenic role on cardiac and bone disease, frequently described in this clinical setting. The aim of this paper is to analyze GH-IGF-1 axis in a cohort of 25 adult patients affected by Β-thalassemia. We found that GH deficiency was present in only 8% of our patients if diagnosis was based on GH peak below 9μg/L to two GH provocative tests instead of only one, and was mainly related to iron overload. On the contrary, IGF-1 production was impaired in a higher percentage of patients (72%), without significant correlation with iron burden. Of note, patients with hepatitis C virus infection showed lower IGF-1 concentrations than uninfected subjects despite a normal GH reserve, suggesting that partial GH insensitivity at the post-receptor level may play a key role in IGF-1 deficiency described in thalassemic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705979

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  9 in total

1.  Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.

Authors:  Massimo Scacchi; Leila Danesi; Agnese Cattaneo; Giovanna Sciortino; Raffaella Radin; Alberto Giacinto Ambrogio; Giovanni Vitale; Emanuela D'Angelo; Nadia Mirra; Laura Zanaboni; Marica Arvigo; Mara Boschetti; Diego Ferone; Paolo Marzullo; Marina Baldini; Elena Cassinerio; Maria Domenica Cappellini; Luca Persani; Francesco Cavagnini
Journal:  Endocrine       Date:  2016-01-29       Impact factor: 3.633

Review 2.  Molecular Aspects of Bone Resorption in β-Thalassemia Major.

Authors:  Najmaldin Saki; Saeid Abroun; Fatemeh Salari; Fakher Rahim; Mohammad Shahjahani; Mohammadi-Asl Javad
Journal:  Cell J       Date:  2015-07-11       Impact factor: 2.479

3.  Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Giancarlo Candini; Mohamed Yassin; Giuseppe Raiola; Maria Concetta Galati; Rania Elalaily; Heba Elsedfy; Nicos Skordis; Piernicola Garofalo; Salvatore Anastasi; Saveria Campisi; Mehran Karimi; Christos Kattamis; Duran Canatan; Yurdanur Kilinc; Praveen Sobti; Bernadette Fiscina; Mohamed El Kholy
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

4.  Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis.

Authors:  Mohamed A Yassin; Ashraf T Soliman; Vincenzo De Sanctis; Mohamed Osman Abdelrahman; Elsaid M Aziz Bedair; Manal AbdelGawad
Journal:  Indian J Endocrinol Metab       Date:  2014-07

5.  An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Duran Canatan; Ploutarchos Tzoulis; Shahina Daar; Salvatore Di Maio; Heba Elsedfy; Mohamed A Yassin; Aldo Filosa; Nada Soliman; Karimi Mehran; Forough Saki; Praveen Sobti; Shruti Kakkar; Soteroula Christou; Alice Albu; Constantinos Christodoulides; Yurdanur Kilinc; Soad Al Jaouni; Doaa Khater; Saif A Alyaarubi; Su Han Lum; Saveria Campisi; Salvatore Anastasi; Maria Concetta Galati; Giuseppe Raiola; Yasser Wali; Ihab Z Elhakim; Demetris Mariannis; Vassilis Ladis; Christos Kattamis
Journal:  Acta Biomed       Date:  2019-01-15

6.  Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis.

Authors:  Mohamed A Yassin; Mohamed O Abdel Rahman; Anas A Hamad; Abdul Razzakh Poil; Mohamed T Abdelrazek; Radwa M Hussein; Nancy A Kassem; Afraa M Fadul; Sarah A Elkourashy; Abdulqadir J Nashwan
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

7.  GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study.

Authors:  I Gagliardi; R Mungari; M R Gamberini; M Fortini; F Dassie; M C Putti; P Maffei; L Aliberti; M Bondanelli; M C Zatelli; M R Ambrosio
Journal:  J Endocrinol Invest       Date:  2022-03-19       Impact factor: 5.467

8.  Growth hormone - insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.

Authors:  Ashraf Soliman; Vincenzo De Sanctis; Mohamed Yassin; Mohamed O Abdelrahman
Journal:  Indian J Endocrinol Metab       Date:  2014-01

9.  Growth and Endocrine Function in Tunisian Thalassemia Major Patients.

Authors:  Naouel Guirat Dhouib; Monia Ben Khaled; Monia Ouederni; Habib Besbes; Ridha Kouki; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.